Brewin Dolphin Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$9.22M	Sell	16,980 -51	-0.3%	-$28.1K	1.01%	16
2022 Q1	$10.1M	Buy	17,031 +1,100	+7%	+$632K	1.13%	17
2021 Q4	$10.6M	Buy	15,931 +161	+1%	+$101K	1.15%	21
2021 Q3	$9.01M	Buy	15,770 +913	+6%	+$501K	1.03%	23
2021 Q2	$7.49M	Buy	14,857 +4,227	+40%	+$1.99M	0.91%	23
2021 Q1	$4.85M	Buy	10,630 +373	+4%	+$178K	0.74%	28
2020 Q4	$4.78M	Buy	10,257 +169	+2%	+$79.2K	0.8%	26
2020 Q3	$4.45M	Buy	10,088 +231	+2%	+$95.4K	0.82%	24
2020 Q2	$3.57M	Buy	+9,857	New	+$3.3M	0.76%	27

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brewin Dolphin Wealth Management's TMO Position: Q2 2022 in Review

Brewin Dolphin Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.3% in Q2 2022, selling an estimated $28.1K and leaving 16,980 shares worth $9.22M. The position accounts for 1.01% of the portfolio, ranked #16.

Brewin Dolphin Wealth Management first reported a position in TMO in Q2 2020 and has held it in 9 quarters since. The position peaked at $10.6M in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Brewin Dolphin Wealth Management held 16,980 shares of Thermo Fisher Scientific worth $9.22M as of Q2 2022.
Brewin Dolphin Wealth Management sold 51 Thermo Fisher Scientific shares in Q2 2022, an estimated $28.1K.
Thermo Fisher Scientific made up 1.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #16 holding.
Brewin Dolphin Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 9 quarters since.
Brewin Dolphin Wealth Management's Thermo Fisher Scientific position peaked at $10.6M in Q4 2021.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.